2826 Pathology Meeting program (PDF)

Sponsors

Organized by

2nd PATHOLOGY MEETING

Call for Abstracts
We encourage young researchers to participate in the meeting by sending oral
presentations to be discussed on the two slide seminars sessions. The two best
abstracts will be granted free registration for the meeting.

ADVANCES INANDMOLECULAR
DIAGNOSTIC PATHOLOGY

Please check the guidelines on the website or kindly contact the technical
secretariat for further information.
Deadline for abstract submission: September 14th, 2018

Target audience

Madrid, October 3-5, 2018

The meeting is aimed at pathologists-in-training and in-practice, molecular
biologists, medical and surgical oncologists, and any other health care
professional interested in recent advances in molecular and diagnostic pathology.

Accreditation
Continuing Education Credits requested to the Spanish National Health System.
With the collaboration of the Educational Committee of the MD Anderson Cancer
Center Madrid.

Venue
Auditorio Rafael del Pino
C/ Rafael Calvo, 39A
Madrid, Spain

Meeting Directors:
Dr. Joseph Khoury
Dr. Juan Fernando García García

Meeting secretariat
Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, Spain
Tel.: +34 91 372 0203 · E-mail: pathologymeeting@doctaforum.com

Registrations: www.mdanderson.es/pathologymeeting

@MDAnderson_ES

Thursday, October 4th, 2018

Friday, October 5th, 2018

08:30 - 08:35

Opening remarks

08:30 - 09:20

08:35 - 10:20

SESSION 2. Hematolymphoid tumors
Moderator

Dr. Enrique Grande, MD Anderson Cancer Center Madrid, Spain

Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

2017 WHO Classification of Hematolymphoid Neoplasms:
practical highlights for general pathologists

09:20 - 10:35

Diagnostic update of aggressive B-cell lymphomas

09:20 - 09:50

10:05 - 10:20

Discussion

09:50 - 10:20

10:20 - 10:50

Coffee Break

10:50 - 13:05

SESSION 3. Keynote symposium

08:35 - 09:20

2nd PATHOLOGY MEETING

ADVANCES INANDMOLECULAR
DIAGNOSTIC PATHOLOGY

11:20 - 11:50

Wednesday, October 3rd, 2018
14:00 - 15:00
15:00 - 15:15

15:15 - 16:05
16:05 - 17:50

Registration & welcome
Welcome / Overview

Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

Inaugural conference

TBC

SESSION 1. Head and neck tumors

16:05 - 16:35
16:35 - 17:05

Familial non-medullary thyroid tumors

Dr. Jose Cameselle, Hospital Clínico Universitario Santiago de Compostela

Salivary gland tumors: updated classification, molecular insights,
biomarkers and targeted therapy

Dr. Diana Bell, The University of Texas MD Anderson Cancer Center, Houston, USA

17:05 - 17:35
17:35 - 17:50

11:50 - 12:20

Discussion

Molecular biology, pathology and natural history of prostate cancer:
a unique malignancy
Dr. Josep Lloreta, Hospital del Mar, Barcelona, Spain

10:20 - 10:35

Discussion

Moderator:

10:35 - 11:05

Coffee Break

Pathology Informatics and big data

11:05 - 12:50

Dr. Mark Routbort, The University of Texas MD Anderson Cancer Center, Houston, USA

Predictive biomarkers for lung cancer immunotherapy

Dr. Ignacio Wistuba,The University of Texas MD Anderson Cancer Center, Houston, USA

SESSION 7. Breast and gynecological tumors

Moderator:

Dr. Xavier Matias-Guiu, Hospital Universitari Arnau Vilanova, Lleida, Spain

11:05 - 11:35

Predictive laboratory tools for breast cancer

Dr. Ayse Sahin, The University of Texas MD Anderson Cancer Center, Houston, USA

11:35 - 12:05

Digital pathology

12:05 - 12:35

12:50 - 13:05

Discussion

12:35 - 12:50

Discussion

13:05 - 14:35

Lunch

12:50 - 14:20

Lunch

14:35 - 16:20

SESSION 4. Gastrointestinal tumors

14:20 - 15:35

Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

12:20 - 12:50

Dr. Víctor Prieto,The University of Texas MD Anderson Cancer Center, Houston, USA

Moderator:

Dr. Santiago González Moreno, MD Anderson Cancer Center Madrid, Spain

14:35 - 15:05
15:05 - 15:35
15:35 - 16:05

Oropharyngeal cancer: two diseases in a very little space
Dr. Ricard Mesía, Institut Català d'Oncologia- Badalona, Barcelona

The evolving scenario of bladder cancer classification

Francisco X. Real, Spanish National Cancer Center (CNIO)

Integration of Next generation sequencing (NGS)
in diagnostic molecular pathology

Moderator:

Dr. M. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain

Dr. George Rassidakis, Cancercenter Karolinska, Stockholm, Sweden

Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

10:50 - 11:20

SESSION 6. Genitourinary tumors

Moderator:

Francisco X. Real, Spanish National Cancer Center (CNIO)

Dr. Joseph Khoury,The University of Texas MD Anderson Cancer Center, Houston, USA

09:20 - 10:05

Plenary Lecture - Integrating combos
in routine practice of metastatic renal cell carcinoma:
clinic versus pathology selection

Hereditary gastric cancer: knowns and unknowns

Dr. Fátima Carneiro, Hospital de Sao Joao, Oporto, Portugal

Updates and issues in appendiceal tumors

Dr. Santiago González Moreno, MD Anderson Cancer Center Madrid, Spain

16:05 - 16:20
16:20 - 18:20

Discussion

14:50 - 15:20
15:20 - 15:35
15:35 - 17:35

Precision medicine does not leave anybody unmoved in the sarcoma field

Dr. Enrique de Álava Casado, Hospital Virgen del Rocío, Seville, Spain

Targeted therapies and immunotherapy in melanoma.
New hope for patients
Discussion

SESSION 9. Slide seminar

Moderator:

Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

Special seminar: four to six cases illustrating the role of molecular pathology
in the clinical decision making processes

SESSION 5. Slide seminar
Special seminar: four to six cases illustrating the role of molecular pathology
in the clinical decision making processes

SESSION 8. Skin, soft tissue and bone tumors

Moderator:

Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA

Moderator:

Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA

Update on pathology of endometrial carcinoma

Dr. Xavier Matias-Guiu, Hospital Universitari Arnau Vilanova, Lleida, Spain

Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA

14:20 - 14:50

Dr. MelissaTaggart, The University of Texas MD Anderson Cancer Center, Houston, USA

Classification and pathology reporting of pseudomyxoma peritonei and
associated appendiceal neoplasia: perspective of the surgical oncologist

Mesenchymal neoplasms of the gynecological tract: current issues

Dr. Anais Malpica,The University of Texas MD Anderson Cancer Center, Houston, USA

17:35 - 17:50

Closing Remarks

Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA